FARMACOCINÉTICA EXPERIMENTAL Y CLÍNICA
Hospital Universitario Virgen Macarena
Sevilla, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario Virgen Macarena (7)
2022
-
Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn's Disease Patients: The SUSTAIN Study
Inflammatory bowel diseases, Vol. 28, Núm. 11, pp. 1725-1736
-
Nationwide COVID-19-EII Study: Incidence, Environmental Risk Factors and Long-Term Follow-Up of Patients with Inflammatory Bowel Disease and COVID-19 of the ENEIDA Registry
Journal of Clinical Medicine, Vol. 11, Núm. 2
-
Using Interpretable Machine Learning to Identify Baseline Predictive Factors of Remission and Drug Durability in Crohn’s Disease Patients on Ustekinumab
Journal of Clinical Medicine, Vol. 11, Núm. 15
2019
-
Recommendations by the Spanish Society of Hospital Pharmacy, the Spanish Society of Oncology Nursing and the Spanish Society of Medical Oncology for the safe management of antineoplastic medication in cancer patients
Clinical and Translational Oncology, Vol. 21, Núm. 4, pp. 467-478
2018
-
Hazardous drugs levels in compounding area surfaces of Hospital Pharmacies Services: Multicentric study
Farmacia Hospitalaria, Vol. 42, Núm. 4, pp. 152-158
2006
-
Low-molecular-weight herapin, bemiparin, in the outpatient treatment and secondary prohylaxis of venous thromboembolism in standard clinical practice: The ESFERA study
International Journal of Clinical Practice, Vol. 60, Núm. 5, pp. 518-525
1999
-
Genetic and phenotypic aspects of phenylalanine hydroxylase deficiency in Spain: Molecular survey by regions
European Journal of Human Genetics, Vol. 7, Núm. 3, pp. 386-392